Literature DB >> 29516398

One Anastomosis Gastric Bypass and Risk of Cancer.

Ahmed Guirat1,2, Hassan Majed Addossari3.   

Abstract

The one anastomosis gastric bypass (OAGB) is a recent procedure, which still raises controversies concerning its presumed role in the genesis of biliary reflux and the risk of developing esophageal or gastric cancer. A review of the literature in order to have evidence in favor of or against the risk of cancer after OAGB. We have conducted a review of the English literature using the MEDLINE database. The theoretical risk of asymptomatic chronic biliary reflux after OAGB exists and may be responsible for gastroesophageal cancer. It is justified to indicate OAGB for patients over 50 years of age. Otherwise, it is reasonable to indicate endoscopic gastroesophageal examination periodically after OAGB in all patients in order to screen asymptomatic biliary reflux.

Entities:  

Keywords:  Biliary reflux; Cancer; One anastomosis gastric bypass

Mesh:

Year:  2018        PMID: 29516398     DOI: 10.1007/s11695-018-3156-5

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  23 in total

1.  A 7-Year Clinical Audit of 1107 Cases Comparing Sleeve Gastrectomy, Roux-En-Y Gastric Bypass, and Mini-Gastric Bypass, to Determine an Effective and Safe Bariatric and Metabolic Procedure.

Authors:  Gurvinder S Jammu; Rajni Sharma
Journal:  Obes Surg       Date:  2016-05       Impact factor: 4.129

2.  A 6-year experience with 1,054 mini-gastric bypasses-first study from Indian subcontinent.

Authors:  K S Kular; N Manchanda; R Rutledge
Journal:  Obes Surg       Date:  2014-09       Impact factor: 4.129

3.  One-anastomosis gastric bypass by laparoscopy: results of the first 209 patients.

Authors:  Miguel Carbajo; Manuel García-Caballero; Miguel Toledano; Diego Osorio; Cándido García-Lanza; José Antonio Carmona
Journal:  Obes Surg       Date:  2005-03       Impact factor: 4.129

4.  Adenocarcinoma of the gastric pouch 26 years after loop gastric bypass.

Authors:  Richard Babor; Michael Booth
Journal:  Obes Surg       Date:  2006-07       Impact factor: 4.129

5.  The mini-gastric bypass: experience with the first 1,274 cases.

Authors:  R Rutledge
Journal:  Obes Surg       Date:  2001-06       Impact factor: 4.129

Review 6.  "Mini" gastric bypass: systematic review of a controversial procedure.

Authors:  Kamal K Mahawar; Neil Jennings; James Brown; Ajay Gupta; Shlok Balupuri; Peter K Small
Journal:  Obes Surg       Date:  2013-11       Impact factor: 4.129

7.  One thousand single anastomosis (omega loop) gastric bypasses to treat morbid obesity in a 7-year period: outcomes show few complications and good efficacy.

Authors:  Jean Marc Chevallier; Gustavo A Arman; Martino Guenzi; Cedric Rau; Mathieu Bruzzi; Nathan Beaupel; Frank Zinzindohoué; Anne Berger
Journal:  Obes Surg       Date:  2015-06       Impact factor: 4.129

8.  Laparoscopic Roux-en-Y vs. mini-gastric bypass for the treatment of morbid obesity: a 10-year experience.

Authors:  Wei-Jei Lee; Kong-Han Ser; Yi-Chih Lee; Jun-Juin Tsou; Shu-Chun Chen; Jung-Chien Chen
Journal:  Obes Surg       Date:  2012-12       Impact factor: 4.129

9.  One thousand consecutive mini-gastric bypass: short- and long-term outcome.

Authors:  Roger Noun; Judith Skaff; Edward Riachi; Ronald Daher; Nayla Abi Antoun; Marwan Nasr
Journal:  Obes Surg       Date:  2012-05       Impact factor: 4.129

10.  Relation between bile acid reflux into the stomach and the risk of atrophic gastritis and intestinal metaplasia: a multicenter study of 2283 cases.

Authors:  Takeshi Matsuhisa; Tetsuo Arakawa; Tetsuo Watanabe; Tadashi Tokutomi; Kouichi Sakurai; Seisuke Okamura; Shinji Chono; Tomoari Kamada; Atsushi Sugiyama; Yoshinori Fujimura; Kenji Matsuzawa; Masanori Ito; Mitsugu Yasuda; Hiroyoshi Ota; Ken Haruma
Journal:  Dig Endosc       Date:  2013-01-29       Impact factor: 7.559

View more
  8 in total

1.  Long-Term Outcomes After One-Anastomosis Gastric Bypass (OAGB) in Morbidly Obese Patients.

Authors:  Maud Neuberg; Marie-Cécile Blanchet; Benoit Gignoux; Vincent Frering
Journal:  Obes Surg       Date:  2020-04       Impact factor: 4.129

2.  Outcomes of Long Pouch Gastric Bypass (LPGB): 4-Year Experience in Primary and Revision Cases.

Authors:  Rui Ribeiro; Sjaak Pouwels; Chetan Parmar; João Pereira; Leonor Manaças; Anabela Guerra; Nuno Borges; João Ribeiro; Octávio Viveiros
Journal:  Obes Surg       Date:  2019-11       Impact factor: 4.129

3.  Esophagogastric Neoplasms Following Bariatric Surgery: an Updated Systematic Review.

Authors:  Mario Musella; Giovanna Berardi; Alessio Bocchetti; Roberta Green; Valeria Cantoni; Nunzio Velotti; Katia Di Lauro; Domenico Manzolillo; Antonio Vitiello; Marco Milone; Giovanni Domenico De Palma
Journal:  Obes Surg       Date:  2019-08       Impact factor: 4.129

4.  One anastomosis gastric bypass versus Roux-en-Y gastric bypass: a 30-day follow-up review.

Authors:  Salvatore Docimo; Jie Yang; Xiaoyue Zhang; Aurora Pryor; Konstantinos Spaniolas
Journal:  Surg Endosc       Date:  2021-02-16       Impact factor: 4.584

Review 5.  Obesity Surgery and Cancer: What Are the Unanswered Questions?

Authors:  Lidia Castagneto-Gissey; James Casella-Mariolo; Giovanni Casella; Geltrude Mingrone
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-15       Impact factor: 5.555

Review 6.  Efficiency and risks of one-anastomosis gastric bypass.

Authors:  Rene Aleman; Emanuele Lo Menzo; Samuel Szomstein; Raul J Rosenthal
Journal:  Ann Transl Med       Date:  2020-03

7.  Evaluation of reflux following sleeve gastrectomy and one anastomosis gastric bypass: 1-year results from a randomized open-label controlled trial.

Authors:  Mario Musella; Antonio Vitiello; Giovanna Berardi; Nunzio Velotti; Marcella Pesce; Giovanni Sarnelli
Journal:  Surg Endosc       Date:  2020-12-02       Impact factor: 4.584

8.  Linear or circular: Anastomotic ulcer after gastric bypass surgery.

Authors:  Aline Schäfer; Philipp Gehwolf; Katrin Kienzl-Wagner; Fergül Cakar-Beck; Heinz Wykypiel
Journal:  Surg Endosc       Date:  2021-06-18       Impact factor: 4.584

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.